Big Pharma “Cost Structure” Needs Attention, Lilly CEO Says
Executive Summary
The pharmaceutical industry needs to make significant changes to its cost structure to remain competitive over the next three to five years, Lilly CEO Sidney Taurel said
You may also be interested in...
Lilly Restructuring Positions Leichleiter As Heir Apparent To CEO Taurel
Lilly's promotion of John Leichleiter to president and chief operating officer positions him as the likely successor to CEO Sidney Taurel
Lilly Restructuring Positions Leichleiter As Heir Apparent To CEO Taurel
Lilly's promotion of John Leichleiter to president and chief operating officer positions him as the likely successor to CEO Sidney Taurel
Roche Vision Of Rx Future Includes IT And China, But Not Large Sales Force
Roche is keeping a close watch on information technology companies as potential emerging competitors for the pharmaceutical industry, CFO Erich Hunziker told the recent J.P. Morgan health care conference in San Francisco